Needing bail-out therapy to stabilise outpatient worsening heart failure highlights a high-risk cohort for recurrent instability

被引:0
|
作者
Fabamwo, F. Fiyinfoluwa [1 ]
Mccambridge, J. [1 ]
Taha, S. [1 ]
Bruno, G. [1 ]
Barrett, M. [1 ]
Mcdonald, K. [1 ]
机构
[1] St Vincents Univ Hosp, Dublin, Ireland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:145 / 145
页数:1
相关论文
共 36 条
  • [1] GASTRIC BYPASS WITH REMNANT RESECTION: A BAIL-OUT STRATEGY FOR HIGH-RISK PATIENTS
    Marrana, Francisco
    Marques, Tatiana Moreira
    Pinto, Diogo Melo
    Barbosa, Lilite
    Moreira, Pedro Soares
    Peixoto, Rita
    Rama, Tiago Figueiredo
    Faria, Gil
    OBESITY SURGERY, 2023, 33 : 395 - 395
  • [2] Management Of Worsening Heart Failure With Subcutaneous Furosemide In A High-risk Ambulatory Patient Cohort
    Patel, Hamza
    Riley, Sarah
    Dorsey, Elissa
    Chambers, Julianne
    Barkdoll, Jessica
    Xie, Michelle m
    Babola, Natalie
    Thomas, Kamishia
    Awuah-asamoah, Ama
    Henry, Leeann
    Heisler, Kara
    Cuomo, Kimberly
    Gilotra, Nisha
    JOURNAL OF CARDIAC FAILURE, 2025, 31 (01)
  • [3] Optimal bail-out and complication management strategies in protected high-risk percutaneous coronary intervention with the Impella
    Sinning, Jan-Malte
    Ibrahim, Karim
    Schroeder, Joerg
    Sef, Davorin
    Burzotta, Francesco
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 : J37 - J42
  • [4] Optimal bail-out and complication management strategies in protected high-risk percutaneous coronary intervention with the Impella
    Sinning, Jan-Malte
    Ibrahim, Karim
    Schroeder, Jorg
    Sef, Davorin
    Burzotta, Francesco
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 : J37 - J42
  • [5] Abnormal plasma ceramides refine high-risk patients with worsening heart failure
    Ren, Lu
    Li, Fengjuan
    Tan, Xin
    Fan, Yangkai
    Ke, Bingbing
    Zhang, Yixin
    Jiang, Hongfeng
    Jia, Lixin
    Wang, Yuan
    Du, Jie
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [6] Symptomatic hypotension and worsening renal function according to guideline directed medical therapy levels in high-risk heart failure patients
    Mewton, N. Nathan
    Courand, P. Y.
    Au, K.
    Duval, A. Jobbe
    Daniel, L.
    Hadjseyd, C. E.
    Duroy, N.
    El Jonhy, N.
    Boussaha, I.
    Haider, L.
    Sebbag, L.
    Berthelot, E.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 218 - 219
  • [7] Tolvaptan reduces the risk of worsening renal function in patients with acute decompensated heart failure in high-risk population
    Matsue, Yuya
    Suzuki, Makoto
    Seya, Mie
    Iwatsuka, Ryota
    Mizukami, Akira
    Nagahori, Wataru
    Ohno, Masakazu
    Matsumura, Akihiko
    Hashimoto, Yuji
    JOURNAL OF CARDIOLOGY, 2013, 61 (1-2) : 169 - 174
  • [8] Cardiac And Inflammatory Biomarkers And New Or Worsening Heart Failure In High-risk Patients With COVID-19
    Namdaran, Parhum
    Findlay, Matthew
    Gibbs, Jeff
    Dranow, Elizabeth
    Shah, Rashmee
    Drakos, Stavros
    Shaw, Robin
    Fang, James
    Shah, Kevin
    JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : S96 - S96
  • [9] Titration of guideline directed medical therapy in a high-risk heart failure patients and impact on heart failure events
    Mewton, Nathan
    Au, K.
    Courand, P. Y.
    Duval, A. Jobbe
    Daniel, L.
    Hadjseyd, C. E.
    Duroy, N.
    El Jonhy, N.
    Boussaha, I.
    Amaz, C.
    Haider, L.
    Sebbag, L.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 215 - 215
  • [10] ACE-inhibitor Therapy at Relatively High Doses and Risk of Renal Worsening in Chronic Heart Failure
    De Vecchis, R.
    Di Biase, G.
    Ariano, C.
    Cioppa, C.
    Giasi, A.
    Ciccarelli, A.
    Pucciarelli, A.
    Cantatrione, S.
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2011, 97 (06) : 507 - 515